Neuroscience

New avenue for study of diseases like multiple sclerosis

A surprising discovery may offer a promising new direction in the study of multiple sclerosis and other diseases of hypomyelination—when axons of neurons are not covered sufficiently in fatty sheaths (myelin), which disrupts ...

Oncology & Cancer

Improving leukemia therapy with targeted treatment approaches

In chronic leukemias, blocking the overactive kinase JAK2 by a targeted therapy approach is only mitigating the patients' symptoms, but cannot truly change the course of the disease. A study by the University of Basel has ...

Alzheimer's disease & dementia

New study identifies likely cause of Alzheimer's disease

Ground-breaking new Curtin University-led research has discovered a likely cause of Alzheimer's disease, in a significant finding that offers potential new prevention and treatment opportunities for Australia's second-leading ...

Arthritis & Rheumatism

Targeting the gut to relieve rheumatoid arthritis

UCL researchers have shown that damage to the lining of the gut plays an important role in the development of rheumatoid arthritis, paving the way for a new approach to treating the disease.

Medications

Transfer RNA may be a new drug for peripheral neuropathy

A team of scientists led by Erik Storkebaum of Radboud University's Donders Institute have deciphered the molecular mechanism underlying a form of Charcot-Marie-Tooth (CMT) peripheral neuropathy. This disease affects both ...

Oncology & Cancer

New discovery enhances understanding of colorectal cancer

MUSC Hollings Cancer Center researchers discovered a novel mechanism showing how a certain gene mutation can allow tumors to evade detection by the immune system in colorectal cancer patients. The study, which was published ...

page 1 from 40